Trademark: 78723291
Word
PROXIMAGEN
Status
Registered
Status Code
800
Status Date
Tuesday, August 7, 2018
Serial Number
78723291
Registration Number
3431171
Registration Date
Tuesday, May 20, 2008
Mark Type
4000
Filing Date
Thursday, September 29, 2005
Published for Opposition
Tuesday, August 21, 2007

Trademark Owner History

Classifications
5 [ Pharmaceutical preparations and substances, namely: analgesics; anesthetics, namely, anesthetics for surgical purposes, general anesthetics, local anesthetics, inhalant anesthetics, and topical anesthetics; anti-emetics; antiepileptics; antineuralgics; antipyretics; antirheumatics; antispasmodics; aphrodisiacs; cardiac, cerebral and hepatic restoratives, namely, analgesics, anti-virals, and anti-inflammatories; cardiac sedatives; cardiac stimulants; cerebral depressants; cerebral stimulants; depressants; digestives; diuretics; emetics; hypnotics; motor depressants; motor excitants, namely, amphetamines, anti-depressants, and psychomotor stimulants, namely, amphetamines; narcotics; nervines; respiratory depressants; respiratory stimulants; sedatives; soporifics, namely, sedatives; stimulants, namely, appetite stimulants, cognitive enhancing agents, namely, neurostimulants, nerve cell growth stimulators and respiratory stimulants; vaso-constrictors; vasodilators; and vascular sedatives; and pharmaceutical preparations and substances for the treatment of diseases and disorders of the alimentary tract and metabolism, blood and blood forming-organs, the cardiovascular system, the endocrine system, the musculoskeletal system, the peripheral nervous system, the genitourinary system, the respiratory system, the reproductive system, the central nervous system, the neurological system, and for psychiatric and psychological disorders, neurodegenerative diseases, cancer, and pain relief and control ]
42 Pharmaceutical research and development services; Product research and development services; Research and development of vaccines and medicines; Research services for others in the fields of the alimentary tract and metabolism, blood and blood forming-organs, the cardiovascular system, the endocrine system, the musculoskeletal system, the peripheral nervous system, the genitourinary system, the respiratory system, the reproductive system, the central nervous system, the neurological system, and for psychiatric and psychological disorders, neurodegenerative diseases, cancer, and pain relief and control; evaluation and testing of compounds for medical purposes, namely analgesics, anesthetics, namely anesthetics for surgical purposes, general anesthetics, local anesthetics, inhalant anesthetics, and topical anesthetics, anti-emetics, antiepileptics, antineuralgics, antipyretics, antirheumatics, antispasmodics, aphrodisiacs, cardiac, cerebral and hepatic restoratives, namely analgesics, anti-virals, and anti-inflammatories, cardiac sedatives, cardiac stimulants, cerebral depressants, cerebral stimulants, depressants, digestives, diuretics, emetics, hypnotics, motor depressants, motor excitants, namely amphetamines, anti-depressants, and psychomotor stimulants, namely, amphetamines, narcotics, nervines, respiratory depressants, respiratory stimulants, sedatives, soporifics, namely sedatives, stimulants, namely appetite stimulants, cognitive enhancing agents, namely, neurostimulants, nerve cell growth stimulators and respiratory stimulants, vaso-constrictors, vasodilators, and vascular sedatives in the fields of Research of the alimentary tract and metabolism, blood and blood forming-organs, the cardiovascular system, the endocrine system, the musculoskeletal system, the peripheral nervous system, the genitourinary system, the respiratory system, the reproductive system, the central nervous system, the neurological system, and for psychiatric and psychological disorders, neurodegenerative diseases, cancer, and pain relief and control; Licensing of intellectual property; Information services in relation to the fields of research of the alimentary tract and metabolism, blood and blood forming-organs, the cardiovascular system, the endocrine system, the musculoskeletal system, the peripheral nervous system, the genitourinary system, the respiratory system, the reproductive system, the central nervous system, the neurological system, and for psychiatric and psychological disorders, neurodegenerative diseases, cancer, and pain relief and control; Advisory and consultation services in the fields of research of the alimentary tract and metabolism, blood and blood forming-organs, the cardiovascular system, the endocrine system, the musculoskeletal system, the peripheral nervous system, the genitourinary system, the respiratory system, the reproductive system, the central nervous system, the neurological system, and for psychiatric and psychological disorders, neurodegenerative diseases, cancer, and pain relief and control
44 Information services in relation to the fields of treatment of the alimentary tract and metabolism, blood and blood forming-organs, the cardiovascular system, the endocrine system, the musculoskeletal system, the peripheral nervous system, the genitourinary system, the respiratory system, the reproductive system, the central nervous system, the neurological system, and for psychiatric and psychological disorders, neurodegenerative diseases, cancer, and pain relief and control; Information services in relation to analgesics, anesthetics, namely anesthetics for surgical purposes, general anesthetics, local anesthetics, inhalant anesthetics, and topical anesthetics, anti-emetics, antiepileptics, antineuralgics, antipyretics, antirheumatics, antispasmodics, aphrodisiacs, cardiac, cerebral and hepatic restoratives, namely analgesics, anti-virals, and anti-inflammatories, cardiac sedatives, cardiac stimulants, cerebral depressants, cerebral stimulants, depressants, digestives, diuretics, emetics, hypnotics, motor depressants, motor excitants, namely amphetamines, anti-depressants, and psychomotor stimulants, namely, amphetamines, narcotics, nervines, respiratory depressants, respiratory stimulants, sedatives, soporifics, namely sedatives, stimulants, namely appetite stimulants, cognitive enhancing agents, namely, neurostimulants, nerve cell growth stimulators and respiratory stimulants, vaso-constrictors, vasodilators, and vascular sedatives; Treatment of the alimentary tract and metabolism, blood and blood forming-organs, the cardiovascular system, the endocrine system, the musculoskeletal system, the peripheral nervous system, the genitourinary system, the respiratory system, the reproductive system, the central nervous system, the neurological system, and for psychiatric and psychological disorders, neurodegenerative diseases, cancer, and pain relief and control; Information services in relation to the fields of treatment of the alimentary tract and metabolism, blood and blood forming-organs, the cardiovascular system, the endocrine system, the musculoskeletal system, the peripheral nervous system, the genitourinary system, the respiratory system, the reproductive system, the central nervous system, the neurological system, and for psychiatric and psychological disorders, neurodegenerative diseases, cancer, and pain relief and control; Advisory and consultation services in the fields of treatment of the alimentary tract and metabolism, blood and blood forming-organs, the cardiovascular system, the endocrine system, the musculoskeletal system, the peripheral nervous system, the genitourinary system, the respiratory system, the reproductive system, the central nervous system, the neurological system, and for psychiatric and psychological disorders, neurodegenerative diseases, cancer, and pain relief and control; Advisory and consultation services in relation to analgesics, anesthetics, namely anesthetics for surgical purposes, general anesthetics, local anesthetics, inhalant anesthetics, and topical anesthetics, anti-emetics, antiepileptics, antineuralgics, antipyretics, antirheumatics, antispasmodics, aphrodisiacs, restoratives, namely analgesics, anti-virals, and anti-inflammatories, cardiac sedatives, cardiac stimulants, cerebral depressants, cerebral stimulants, depressants, digestives, diuretics, emetics, hypnotics, motor depressants, motor excitants, namely amphetamines, anti-depressants, and psychomotor stimulants, namely, neurostimulants, narcotics, nervines, respiratory depressants, respiratory stimulants, sedatives; Medical testing and diagnostic services; Provision of medical and pharmaceutical information; and Medical and pharmaceutical consultation

Trademark Events
Feb 17, 2021
Automatic Update Of Assignment Of Ownership
Aug 8, 2018
Automatic Update Of Assignment Of Ownership
Aug 7, 2018
Notice Of Acceptance Of Sec. 8 & 9 - E-Mailed
Aug 7, 2018
Registered And Renewed (First Renewal - 10 Yrs)
Aug 7, 2018
Registered - Sec. 8 (10-Yr) Accepted/Sec. 9 Granted
Aug 3, 2018
Teas Section 8 & 9 Received
May 20, 2017
Courtesy Reminder - Sec. 8 (10-Yr)/Sec. 9 E-Mailed
Jun 5, 2014
Notice Of Acceptance Of Sec. 8 & 15 - E-Mailed
Jun 5, 2014
Registered - Partial Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
May 20, 2014
Registered - Sec. 8 (6-Yr) & Sec. 15 Filed
Jun 4, 2014
Case Assigned To Post Registration Paralegal
May 20, 2014
Teas Section 8 & 15 Received
May 20, 2008
Registered-Principal Register
Apr 14, 2008
1(B) Basis Deleted; Proceed To Registration
Apr 9, 2008
Notice Of Allowance Cancelled
Apr 9, 2008
Teas Delete 1(B) Basis Received
Nov 13, 2007
Noa Mailed - Sou Required From Applicant
Aug 21, 2007
Published For Opposition
Aug 1, 2007
Notice Of Publication
Jul 19, 2007
Law Office Publication Review Completed
Jul 16, 2007
Approved For Pub - Principal Register
Jul 16, 2007
Examiner's Amendment Entered
Jul 16, 2007
Notification Of Examiners Amendment E-Mailed
Jul 16, 2007
Examiners Amendment E-Mailed
Jul 16, 2007
Examiners Amendment -Written
Jul 16, 2007
Previous Allowance Count Withdrawn
Jul 10, 2007
Approved For Pub - Principal Register
Jul 10, 2007
Examiner's Amendment Entered
Jul 10, 2007
Notification Of Examiners Amendment E-Mailed
Jul 10, 2007
Examiners Amendment E-Mailed
Jul 10, 2007
Examiners Amendment -Written
Jul 9, 2007
Examiner's Amendment Entered
Jul 9, 2007
Notification Of Examiners Amendment E-Mailed
Jul 9, 2007
Examiners Amendment E-Mailed
Jul 9, 2007
Examiners Amendment -Written
Jul 5, 2007
Examiner's Amendment Entered
Jul 5, 2007
Notification Of Examiners Amendment E-Mailed
Jul 5, 2007
Examiners Amendment E-Mailed
Jul 5, 2007
Examiners Amendment -Written
Jun 15, 2007
Amendment From Applicant Entered
Jun 15, 2007
Correspondence Received In Law Office
Jun 7, 2007
Assigned To Lie
May 21, 2007
Paper Received
Nov 27, 2006
Non-Final Action E-Mailed
Nov 27, 2006
Non-Final Action Written
Nov 3, 2006
Amendment From Applicant Entered
Oct 4, 2006
Correspondence Received In Law Office
Oct 10, 2006
Paper Received
Apr 6, 2006
Non-Final Action E-Mailed
Apr 6, 2006
Non-Final Action Written
Apr 3, 2006
Assigned To Examiner
Feb 16, 2006
Amendment From Applicant Entered
Feb 2, 2006
Correspondence Received In Law Office
Feb 2, 2006
Paper Received
Oct 4, 2005
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24